Further processing options
3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
Saved in:
Journal Title: | Frontiers in Pharmacology |
---|---|
Authors and Corporations: | , , , , , , , |
In: | Frontiers in Pharmacology, 9, 2018 |
Type of Resource: | E-Article |
Language: | Undetermined |
published: |
Frontiers Media SA
|
Subjects: |